|
FUBP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.48460000000073E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.72520000005527E-06 |
| Normal-vs-Stage2 |
8.535500E-02 |
| Normal-vs-Stage3 |
8.121700E-02 |
| Normal-vs-Stage4 |
5.736400E-01 |
| Stage1-vs-Stage2 |
4.336800E-01 |
| Stage1-vs-Stage3 |
3.496200E-01 |
| Stage1-vs-Stage4 |
2.423000E-01 |
| Stage2-vs-Stage3 |
9.706200E-01 |
| Stage2-vs-Stage4 |
5.724600E-01 |
| Stage3-vs-Stage4 |
6.032000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.18650000000698E-05 |
| Normal-vs-AfricanAmerican |
5.081400E-03 |
| Normal-vs-Asian |
1.727780E-01 |
| Caucasian-vs-AfricanAmerican |
9.149000E-01 |
| Caucasian-vs-Asian |
6.846600E-01 |
| AfricanAmerican-vs-Asian |
6.505400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.16160000002341E-06 |
| Normal-vs-Female |
1.860040E-01 |
| Male-vs-Female |
7.149800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.447400E-04 |
| Normal-vs-Extreme_Weight |
1.86909999999596E-05 |
| Normal-vs-Obese |
1.904250E-01 |
| Normal-vs-Extreme_Obese |
6.038400E-02 |
| Normal_Weight-vs-Extreme_Weight |
7.828800E-01 |
| Normal_Weight-vs-Obese |
1.170750E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.214600E-01 |
| Extreme_Weight-vs-Obese |
3.422400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.008000E-01 |
| Obese-vs-Extreme_Obese |
4.217000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.944600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.907800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.50030000043178E-07 |
| Normal-vs-Age(81-100Yrs) |
1.304470E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.753600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.608580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.237000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.016900E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.349410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.078600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.755100E-04 |
| Normal-VS-Type2 PRCC |
1.383970E-04 |
| Normal-VS-KIRP CIMP |
8.135600E-01 |
| Normal-VS-Unclassified PRCC |
4.509600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.826000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.434390E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.616200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.467900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.136800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.097200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.77300000032177E-07 |
| Normal-vs-N1 |
8.002600E-01 |
| Normal-vs-N2 |
9.814200E-02 |
| N0-vs-N1 |
2.192300E-02 |
| N0-vs-N2 |
5.135400E-01 |
| N1-vs-N2 |
5.498600E-01 |
|
|
